subject: Cytology And Hpv Testing World Markets --new Medical Report By Aarkstore Enterprise [print this page] Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by both external (chemicals, radiation and viruses) and internal (hormones, immune conditions and inherited mutations) factors. Causal factors may act together or in sequence to initiate or promote carcinogenesis. Ten or more years often pass between exposures or mutations and detectable cancer. Cancer is treated by surgery, radiation, chemotherapy, hormones and immunotherapy. The purpose of this Publications report is to describe the specific segment of the diagnostic market aimed at analysis cytology (the examination of cells using optical microscopy methods) specimens derived from the human female reproductive tract. It examines the measurement devices and their reagents and supplies used in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the diagnosis and monitoring of disease. The study describes the analytical methods used to separate, isolate, characterize and quantitate cells, DNA and proteins complex in biological systems related to the diagnosis and treatment of disease of the female reproductive tract, such as the cervix and vagina. The emphasis is on those companies and products that are actively developing and marketing laboratory instrumentation, reagents and supplies for performing cytology and related molecular diagnostic tests, such as human papillomavirus (HPV) and other inflammatory and sexually-transmitted diseases.
Table of Contents :
1. Overview 6
1.1 Statement of Report 6
1.2 About this Report 6
1.3 Scope of the Report 7
1.4 Objectives 8
1.5 Methodology 8
2. Introduction to Cancer Biology and the Diagnostic Industry 10
2.1 Cancer 10
2.1.1 The Disease 10
2.1.2 Metastasis 10
2.1.3 Demographics and Statistics of Cancer 11
2.2 The Drivers of the Biotech and Diagnostics Industry 18
2.2.1 Top Ten Biotech Corporations 19
2.2.2 Technological Innovation 19
2.2.3 Government Funding 20
2.2.4 Pharmaceutical Development 20
2.3 Outlook for Tumor Markers 21
2.4 The Cancer Market 22
3. Cervical Cytology Testing Overview 25
3.1 Sector Background 25
3.2 Market Opportunity 25
3.3 Cervical Cancer 25
3.3.1 Screening for Cervical Cancer 26
3.3.2 Screening Procedures and Pap Smear Technology 27
4. Human Papillomavirus (HPV) Testing Overview 31
4.1 Market Overview 31
4.1.1 Human Papillomavirus 31
4.1.2 North American Market 34
4.1.3 European Market 35
4.1.4 Latin American Market 35
4.2 Hybrid Capture 2 Technology 35
4.3 Histology Market Overview 37
5. Cytology Market Structure 40
5.1 Key Players 40
5.1.1 BD, TriPath 40
5.1.2 Cytyc (Acquired by Hologic) 40
5.1.3 CytoCore, Inc. (formerly known as Molecular Diagnostics, Inc.) 41
